Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-25

Clinical Trial Update: Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated whether magnesium sulfate affects sugammadex reversal of rocuronium-induced blockade in gynecology patients with aggravated p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)
  • Rocuronium (rocuronium bromide)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Kocaeli University | Conditions: Pre-eclampsia Aggravated | Phase 4 | Status: COMPLETED | Results posted: 2014-02-25